Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. Published

    Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

    Kesselring, A. M., Wit, F. W., Sabin, C. A., Lundgren, Jens, Gill, M. J., Gatell, J. M., Rauch, A., Montaner, J. S., de Wolf, F., Reiss, P., Mocroft, A. & NN, N., 2009, In: AIDS. 23, 13, p. 1689-99 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy: A Multinational Prospective Cohort Study

    Chammartin, F., Lodi, S., Logan, R., Ryom, L., Mocroft, A., Kirk, Ole, D’arminio Monforte, A., Reiss, P., Phillips, A., El-sadr, W., Hatleberg, C. I., Pradier, C., Bonnet, F., Law, M., De Wit, S., Sabin, C., Lundgren, Jens & Bucher, H. C., 1 Jun 2021, In: Annals of Internal Medicine. 174, 6, p. 768-776 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial

    El-Sadr, W. M., Grund, B., Neuhaus, J., Babiker, A., Cohen, C. J., Darbyshire, J., Emery, S., Lundgren, Jens, Phillips, A., Neaton, J. D. & SMART Study Group, S. S. G., 2008, In: Annals of Internal Medicine. 149, 5, p. 289-99 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.

    Olsen, C. H., Gatell, J., Ledergerber, B., Katlama, C., Friis-Møller, N., Weber, J., Horban, A., Staszewski, S., Lundgren, Jens & Phillips, A., 2005, In: AIDS. 19, p. 319-330

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Risk of Bacterial, Viral, and Fungal Infections in Patients With Solid Malignant Tumors Treated With Curative Intent Radiation Therapy

    Terrones-Campos, C., Ledergerber, B., Specht, Lena, Vogelius, Ivan R. , Helleberg, M. & Lundgren, Jens, 2022, In: Advances in Radiation Oncology. 7, 6, 16 p., 100950.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    PARTNER Study Group, P. S. G., 15 Jun 2019, In: Lancet Oncology. 393, 10189, p. 2428-2438 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts

    Mocroft, A., Staszewski, S., Weber, R., Gatell, J., Rockstroh, J., Gasiorowski, J., Panos, G., Monforte, A. D., Rakhmanova, A., Phillips, A. N., Lundgren, Jens & Eurosida Study Group, E. S. G., 2007, In: Antiviral Therapy. 12, 3, p. 325-33 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?

    Ekenberg, C., Lodding, I. P., Wareham, N. E., Sørensen, Søren Schwartz, Sengeløv, Henrik, Gustafsson, Finn, Rasmussen, A., Perch, Michael, Lundgren, Jens & Helleberg, M., 2017, In: European Journal of Clinical Microbiology & Infectious Diseases. 36, 12, p. 2391-2398

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

    Worm, S. W., Sabin, C., Weber, R., Reiss, P., El-Sadr, W., Dabis, F., De Wit, S., Law, M., Monforte, A. D., Friis-Møller, N., Kirk, Ole, Fontas, E., Weller, I., Phillips, A. & Lundgren, Jens, 1 Feb 2010, In: Journal of Infectious Diseases. 201, 3, p. 318-30 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study

    Phillips, A. N., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D., Wensing, A., Lundgren, J. D., De Luca, A., Pillay, D., Mellors, J., Cambiano, V., Bansi-Matharu, L., Nakagawa, F., Kalua, T., Jahn, A., Apollo, T., Mugurungi, O., Clayden, P., Gupta, R. K., Barnabas, R. & 4 others, Revill, P., Cohn, J., Bertagnolio, S. & Calmy, A., 2019, In: The Lancet HIV. 6, 2, p. e116-e127

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13961